This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 Oct. 29 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 Jul. 30 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Approves the Election of Guo De'an as Independent Director Apr. 28 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 Apr. 26 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 Apr. 18 CI
Tibet Cheezheng Tibetan Medicine's Profit Rises 29.5% in 2023; Shares Up 5% Feb. 23 MT
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 23-10-26 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 23-07-28 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 23-04-27 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 23-04-27 CI
Tibet Cheezheng Tibetan Medicine Logs 34.1% Drop in 2022 Profit 23-02-20 MT
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 22-10-27 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 22-07-28 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 22-04-28 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 22-02-17 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 21-10-25 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 21-07-27 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 21-04-26 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 21-04-15 CI
Gansu Foge Tibetan Medicine Co., Ltd. announced that it expects to receive CNY 790.500216 million in funding from Tibet Cheezheng Tibetan Medicine Co., Ltd. and other investors 20-12-03 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020 20-10-22 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd.(XSEC:002287) added to FTSE All-World Index 20-09-21 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd.(XSEC:002287) added to S&P Global BMI Index 20-09-21 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020 20-08-27 CI
Gansu Foge Tibetan Medicine Co., Ltd. announced that it has received CNY 192.9802 million in funding from Tibet Cheezheng Tibetan Medicine Co., Ltd. 20-08-19 CI
Chart Tibet Cheezheng Tibetan Medicine Co., Ltd.
002287: Dynamic Chart
Logo Tibet Cheezheng Tibetan Medicine Co., Ltd.
Tibet Cheezheng Tibetan Medicine Co., Ltd is a China-based company, principally engaged in the research, development, manufacture and distribution of Tibetan medicines. The Company primarily offers medicines under emplastrum, ointment, granule, crude drugs and others. The Company's products include external pain relieving series, including Cheezheng Xiaotong emplastrum, Qingpeng ointment and Baimai ointment, as well as oral medicine series. The Company distributes its products within domestic market and to overseas markets.
Employees
3,091
More about the company
  1. Stock Market
  2. Equities
  3. 002287 Stock
  4. News Tibet Cheezheng Tibetan Medicine Co., Ltd.
  5. Tibet Cheezheng Tibetan Medicine's Profit Rises 29.5% in 2023; Shares Up 5%